Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron Emission Tomography Computed Tomography | 4 | 2024 | 62 | 2.120 |
Why?
|
| Sarcoidosis | 2 | 2023 | 33 | 1.490 |
Why?
|
| Lymphadenopathy | 2 | 2021 | 23 | 1.330 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2026 | 21 | 0.920 |
Why?
|
| Lung Neoplasms | 4 | 2026 | 708 | 0.870 |
Why?
|
| Terminology as Topic | 1 | 2026 | 144 | 0.860 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 102 | 0.810 |
Why?
|
| Cerebral Infarction | 1 | 2024 | 85 | 0.810 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 196 | 0.790 |
Why?
|
| Melanoma | 2 | 2023 | 333 | 0.650 |
Why?
|
| Pancreas | 3 | 2018 | 153 | 0.640 |
Why?
|
| Vaccination | 1 | 2021 | 384 | 0.550 |
Why?
|
| Biliary Tract | 1 | 2018 | 9 | 0.550 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 72 | 0.520 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 116 | 0.500 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2026 | 1659 | 0.450 |
Why?
|
| Neoplasms | 1 | 2021 | 1372 | 0.320 |
Why?
|
| Humans | 22 | 2026 | 65463 | 0.280 |
Why?
|
| Diagnosis, Differential | 5 | 2021 | 990 | 0.240 |
Why?
|
| Immunoconjugates | 2 | 2021 | 95 | 0.230 |
Why?
|
| Ultrasonography | 2 | 2018 | 491 | 0.220 |
Why?
|
| Radioactive Tracers | 1 | 2024 | 3 | 0.210 |
Why?
|
| Pancreatitis | 2 | 2014 | 96 | 0.200 |
Why?
|
| Biological Transport | 1 | 2024 | 292 | 0.200 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 9 | 0.190 |
Why?
|
| Bone Marrow | 1 | 2023 | 176 | 0.180 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2022 | 33 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2022 | 28 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 115 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 175 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2022 | 160 | 0.160 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 67 | 0.160 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2020 | 6 | 0.160 |
Why?
|
| Ampulla of Vater | 1 | 2020 | 12 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 50 | 0.160 |
Why?
|
| Rectal Neoplasms | 1 | 2022 | 139 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 498 | 0.150 |
Why?
|
| Patient Safety | 1 | 2022 | 281 | 0.140 |
Why?
|
| Simulation Training | 1 | 2019 | 66 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 2250 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 50 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 219 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2022 | 492 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2017 | 23 | 0.130 |
Why?
|
| Pelvic Pain | 1 | 2016 | 20 | 0.120 |
Why?
|
| Abdomen, Acute | 1 | 2016 | 23 | 0.120 |
Why?
|
| Disease Progression | 1 | 2021 | 1223 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2016 | 55 | 0.120 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 75 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 348 | 0.120 |
Why?
|
| Atrial Flutter | 1 | 2016 | 33 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 35 | 0.120 |
Why?
|
| Radiology | 1 | 2019 | 263 | 0.110 |
Why?
|
| Male | 9 | 2024 | 31187 | 0.110 |
Why?
|
| Jejunal Diseases | 1 | 2014 | 6 | 0.110 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 14 | 0.110 |
Why?
|
| Choristoma | 1 | 2014 | 23 | 0.110 |
Why?
|
| Colon, Descending | 1 | 2014 | 1 | 0.110 |
Why?
|
| Communication | 1 | 2019 | 600 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 263 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 2014 | 35 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2016 | 322 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 389 | 0.090 |
Why?
|
| Aged | 2 | 2024 | 15052 | 0.080 |
Why?
|
| Acute Disease | 3 | 2016 | 663 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 5806 | 0.070 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2007 | 22 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 40 | 0.070 |
Why?
|
| Stroke | 1 | 2016 | 1213 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2007 | 54 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 231 | 0.060 |
Why?
|
| Female | 6 | 2022 | 34193 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 14 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 93 | 0.040 |
Why?
|
| Rectum | 1 | 2022 | 97 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2021 | 75 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 75 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 377 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 223 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2020 | 131 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 552 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 744 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2019 | 214 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 847 | 0.030 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 1 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 5 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 465 | 0.030 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 7 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 10 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 326 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2016 | 19 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2016 | 8 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 50 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 70 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 875 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 97 | 0.030 |
Why?
|
| Aphasia | 1 | 2016 | 47 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 682 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2016 | 109 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 610 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 18387 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1334 | 0.030 |
Why?
|
| Rupture | 1 | 2014 | 24 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 732 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2492 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 193 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2016 | 529 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 432 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2019 | 803 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2390 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6929 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8148 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1564 | 0.020 |
Why?
|
| Copper Radioisotopes | 1 | 2007 | 1 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 167 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 315 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1567 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17461 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 11138 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 21381 | 0.000 |
Why?
|